Products for Research Use Only
RegisterLogin

Nicotinamide riboside

CAT: 0804-HY-123033Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-123033Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Nicotinamide riboside, an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3. Nicotinamide riboside is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet-induced metabolic abnormalities[1]. Nicotinamide riboside reduces cognitive deterioration in a transgenic mouse model of Alzheimer’s disease[2].
CAS Number
1341-23-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite; Sirtuin
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/nicotinamide-riboside.html
Purity
99.99
Solubility
10 mM in DMSO
Smiles
NC(C1=C[N+]([C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)=CC=C1)=O
Molecular Formula
C11H15N2O5
Molecular Weight
255.25
Precautions
H302, H315, H319, H335
References & Citations
[1]Cantó C, et al. The NAD (+) precursor nicotinamide riboside enhances oxidative metabolism and protectsagainst high-fat diet-induced obesity. Cell Metab. 2012 Jun 6;15 (6) :838-47.|[2]Bing Gong, et al. Nicotinamide Riboside Restores Cognition Through an Upregulation of Proliferator-Activated Receptor-γ Coactivator 1α Regulated β-Secretase 1 Degradation and Mitochondrial Gene Expression in Alzheimer's Mouse Models. Neurobiol Aging. 2013 Jun;34 (6) :1581-8.|[3]Collin D Heer, et al. Coronavirus and PARP Expression Dysregulate the NAD Metabolome: A Potentially Actionable Component of Innate Immunity. bioRxiv. 2020 Apr 30;2020.04.17.047480.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite; SIRT1; SIRT3
Citation 01
ACS Appl Mater Interfaces. 2024 May 1;16 (17) :21383-21399.|ACS Appl Mater Interfaces. 2025 Aug 20;17 (33) :47497-47511.|Br J Pharmacol. 2025 Apr 13.|Cell Biosci. 2021 Nov 10;11 (1) :192.|Cells. 2023 Oct 2;12 (19) :2396.|Commun Biol. 2023 Mar 2;6 (1) :235.|FASEB J. 2022 Jul;36 (7) :e22418.|FASEB J. 2024 Apr 15;38 (7) :e23600.|Mol Ther. 2023 Jan 4;31 (1) :193-210.|Redox Biol. 2022 Nov:57:102507.|Res Sq. 2025 Mar 31.|Basic Res Cardiol. 2024 Jun;119 (3) :403-418.|Bone Res. 2025 Jan 26;13 (1) :18.|Curr Issues Mol Biol. 2024 Feb 1;46 (2) :1291-1307.|Exp Eye Res. 2024 Nov:248:110126.|Int J Biol Macromol. 2025 Jul 5;320 (Pt 1) :145750.|Invest Ophthalmol Vis Sci. 2024 Jul 1;65 (8) :1.|J Ginseng Res. 2025 May 10.|Nat Commun. 2023 Jan 16;14 (1) :240.|Toxicol Appl Pharmacol. 2024 Aug 9:117066.

Related Products

CatalogName
HY-B0150-01Nicotinamide
HY-101055-01Kinetin riboside
HY-W007791-01Chloropurine riboside
HY-117821-01Creatine riboside
HY-W713076-01Dihydrozeatin riboside
HY-101397-01Allopurinol riboside
HY-W614507-01Dihydronicotinamide riboside
HY-B0150S2Nicotinamide-13C6
HY-B0150S3Nicotinamide-d3
HY-B0150R-01Nicotinamide (Standard)

Alternative Products

CatalogName
T13795-01Nicotinamide riboside
329479Nicotinamide Riboside Chloride
T40059Nicotinamide riboside tartrate
MBS5800375Nicotinamide riboside malate
564087Nicotinamide Riboside Triflate

Popular Products